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Letters to the Editor 
 
Vestibular and ventilatory dysfunction in sensory and autonomic 
neuropathy associated with primary Sjogren’s syndrome 
 
 
Subacute sensory neuropathy was described by Denny-Brown in association with carcinoma1 
and has recently been described in association with primary Sjögren’s syndrome (SS).2  The 
primary pathology is in the dorsal root ganglia and consists of lymphocytic infiltration and 
neuronal cell destruction. We describe a patient with primary SS with sensory and autonomic 
neuropathy and the previously undescribed clinical features of vestibular and ventilatory 
dysfunction. 
A 38 year old man presented with difficulty with walking for one month. He also com-
plained of pain and tingling in the feet and hands, patchy areas of abnormal sensation on the 
trunk and perioral paraesthesiae. He had experienced grittiness and dryness of the eyes and a 
dry mouth for 6 months and had keratoconjunctivitis sicca on ophthalmological examination 
about 4 months before his neurological presentation. His pupils reacted sluggishly to light but 
the visual fields and optic fundi were normal. There was reduced sensation in all divisions of 
the fifth cranial nerve bilaterally, although there was some sparing of the perioral region, and 
the corneal reflexes and corneal sensation were reduced. In the limbs the power was normal. 
The deep tendon reflexes were absent. In the upper limbs there was reduction of pinprick and 
light touch sensation in a distal distribution and loss of vibration sense and proprioception up 
to and including the wrists. In the lower limbs, pinprick sensation was reduced in the toes, 
light touch was absent up to the thighs and vibration sensation was absent below the iliac 
crests. There was severe impairment of proprioception up to and including the knees. 
Romberg’s sign was positive and the gait was severely ataxic. There was bilateral punctate 
keratitis in the interpalpebral distribution and the Schirmer’s test was 14 mm on the right and 
4 mm on the left (normal > 5). On later examination, the Schirmer’s test revealed no 
lacrimadon from either eye. 
The significant results of investigations were that the RA latex test was negative, 
anticardiolipin antibody level was 8 (normal < 20) and smooth muscle antibody titre was 
1:40. Screening for other autoantibodies, including extractable nuclear antigens, was negative. 
CSF protein was initially 660 mg/L (normal < 400), CSF IgG was 55 mg/L (normal 10-60) 
and CSF IgG/albumin was 0.14 (normal < 0.11). On a later occasion the CSF protein level 
was 1,100 mg/L. CSF electrophoresis did not reveal oligoclonal bands. Motor nerve 
conduction velocity was normal but sensory action potentials were absent in the right median, 
ulnar and sural nerves. A sural nerve biopsy showed axonal degeneration, with loss of large 
diameter fibres, and a sparse perivascular lymphoid infiltrate around occasional perineurial 
vessels. Biopsies of the lip and conjunctiva were normal. No evidence of malignancy was 
found. Autonomic function was tested using bedside techniques on six occasions. Initially the 
patient showed an abnormal heart rate response to the Valsalva manoeuvre, deep breathing 
and to standing. Later he also showed postural hypotension and reduction in the blood 
pressure response to hand grip. 
Because of the xerophthalmia and xerostomia, and the finding of punctate keratitis on Rose-
Bengal staining, a diagnosis of primary SS causing sensory and autonomic neuropathy was 
made. He was treated with intravenous methylprednisolone (500 mg per day for 5 days) and 
then given oral prednisone (100 mg/day). His gait improved and there was some improvement 
in joint position sense, although the numbness of the limbs and painful dysaesthesiae 
persisted. After one month the steroid dose was tapered. When the prednisone dose was 
reduced to 80 mg/day he became worse and developed tight band-like sensations about the 
trunk. He developed dyspnoea and tachypnoea with resting respiratory rates up to 30 per 
minute. At this time he showed no signs of anxiety or emotional distress. Spirometry was 
normal and a chest radiograph was normal. Blood gas analysis showed a compensated 
respiratory alkalosis. Ten weeks after the first course, he was given a further course of 5 days 
of 500 mg/day of intravenous methylprednisolone and then continued on reducing doses of 
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oral prednisone and he was treated with azathioprine (125 mg/day). Despite this, he then com-
plained of blurred vision and intermittent oscillopsia. On examination, horizontal nystagmus 
was present for several weeks. Electronystagmography showed absent responses to caloric 
stimulation on two occasions. CT and MRI scans of the brain were normal. He was treated 
with both plasma exchange and intravenous gamma globulin and continued on prednisone 
and azathioprine for 8 months. At review 18 months after his first presentation, he continued 
to have severe ataxia of gait and widespread sensory loss with no remaining normal pain 
sensibility. His pattern of breathing had changed so that he no longer had tachypnoea, but had 
episodes when he noticed that he had ceased breathing. 
His wife noticed periods of apnoea lasting several minutes during sleep. A recording of 
respiration during sleep was performed on one occasion but apnoeic episodes were not 
observed. 
Our patient had primary Sjögren’s syndrome and had clinical and electrophysiological 
evidence of a subacute sensory neuropathy which has been well described in primary SS.2 He 
also had bilateral trigeminal sensory neuropathy and evidence of autonomic dysfunction 
which are also reported to occur in primary SS.2, 3 There was no evidence of CNS disease, 
which is described in SS.4 
The new features in this patient are the vestibular and ventilatory abnormalities. The 
ventilatory problems consisted of dyspnoea and tachypnoea but later changed to intermittent 
apnoea. We propose that this may have been due to involvement of primary sensory neurons 
of pulmonary stretch receptors in the nodose ganglia by the neuropathic process. The 
pulmonary stretch receptors mediate the Hering-Breuer reflex which results in the termination 
of inspiration and the initiation of expiration. The initial dyspnoea and tachypnoea may have 
occurred as an irritative phenomenon while the later apnoea may have been due to neuronal 
loss. Similar involvement, in the nodose ganglion, of the primary sensory neurons of the 
carotid and aortic body chemoreceptors may also have contributed to the ventilatory disturb-
ance. Slowing of respiration has been observed in rabbits with experimental allergic 
encephalomyelitis, where there is major pathology in the dorsal root ganglia, and has been 
attributed possibly to lesions in the nodose ganglia interrupting the Hering-Breuer reflex.5 
Our patient’s oscillopsia may be due to a peripheral vestibular lesion as 
electronystagmography showed absent caloric responses and there was no evidence of a 
central lesion on CT or MRI. We suggest that his vestibular dysfunction represents an exten-
sion of the pathological process to include the primary sensory neurons of the vestibular 
(Scarpa’s) ganglia. Vestibular neuropathy has not previously been reported in subacute 
sensory neuropathy. 
In our patient, high dose corticosteroid treatment was beneficial, but the patient relapsed 
when the dose was reduced. Treatment with azathioprine, and intravenous gamma globulin 
were of no apparent benefit. After the end of treatment he remained stable. The clinical 
response of this patient suggests that benefit can be obtained by immunosuppressive treatment 
during the initial phase of inflammation. 
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